In addition to CREB and NF1, previously established targets of miR-9 in glioma stem cells, such as CAMTA1 [18] and JAK1/2 [35], might contribute to the function of miR-9 in glioma cells, although further investigation will be required. The gene discussed is CAMTA1; the disease is central nervous system cancer.